Literature DB >> 15887470

Angiotensin-converting enzyme polymorphism in healthy young subjects: relationship to left ventricular mass and functions.

Dursun Dursunoglu1, Harun Evrengül, Halil Tanriverdi, Günfer Turgut, Osman Genç, H Asuman Kaftan, Mustafa Kilic.   

Abstract

OBJECTIVES: Angiotensin-converting enzyme (ACE) is a key enzyme in the production of angiotensin II and thus may participate in the modulation of cardiac growth. The cloning of the ACE gene has made it possible to identify a deletion (D)-insertion (I) polymorphism that appears to affect the level of serum ACE activity. The aim of the study is to analyse the ACE gene I/D polymorphisms in healthy young subjects and to evaluate its relationship to left ventricular mass and functions.
METHODS: 38 women and 40 men (mean age 21.1 +/- 1.7 and 21.4 +/- 1.7 years) were studied. They underwent complete echocardiographic assessment and analysis of ACE insertion (I) and deletion (D) allele frequencies in peripheral blood by polymerase chain reaction. Thickness of interventricular septum (IVS) and posterior wall (LVPW) and left ventricular mass (LVM) and LVM index (LVMI) were measured by M-mode. Left ventricular ejection fraction (LVEF) was calculated by Simpson's method.
RESULTS: There was no statistically significant difference among the DD, DI and II genotypes, concerning age, body mass index, heart rate, systolic and diastolic blood pressures.The thickness of IVS (9.5 mm), LVPW (9.0 mm), LVM (204.5 g) and LVMI (105.5 g/m2) in DD genotypes were higher than both DI (8.3 mm; 8.1 mm; 168.1 g; 90.9 g/m2) and II genotypes (8.2 mm; 7.0 mm; 141.7 g; 77.8 g/m2) in men, but not in women. LVEF among the 3 genotypes were not statistically different.
CONCLUSION: Our findings suggest that left ventricular hypertrophy is partially determined by genetic disposition especially in men but not in women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887470     DOI: 10.2143/AC.60.2.2005025

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  3 in total

Review 1.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

2.  ACE gene polymorphism and cardiac structure in patients with insulin resistance.

Authors:  Fulya Akin; Sebahat Turgut; Dursun Dursunoglu; Gunfer Turgut; Ugur Karasu; Sukru Gur
Journal:  Mol Biol Rep       Date:  2008-03-18       Impact factor: 2.316

3.  Impact of angiotension I converting enzyme gene I/D polymorphism on running performance, lipid, and biochemical parameters in ultra-marathoners.

Authors:  Yu-Hui Chiu; Jiun-I Lai; Chia-Ying Tseng; Shih-Hao Wang; Li-Hua Li; Wei-Fong Kao; Chorng-Kuang How; Wen-Han Chang; Chin-Yi Hsieh
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.